Peak Bio- Warrants (05/01/2026)'s total revenue is $0, below the sector sector average of $1.4B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2025
Trailing 12 months ending Jun 2025
As of the most recent data (June 2025), PKBOW shows a total revenue of $0. That compares with $280K in the prior-year period — down 100.0% year over year. That is below the sector sector average of $1.4B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PKBOW's total revenue is now $0 (was $280K) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Peak Bio- Warrants (05/01/2026) is outperforming or lagging.
The its sector sector average total revenue is about $1.4B. Peak Bio- Warrants (05/01/2026) is at $0, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how PKBOW stacks up against individual peers as well.
Tracking PKBOW's total revenue over time shows whether Peak Bio- Warrants (05/01/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $280K in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total revenue page, Stockcircle has Peak Bio- Warrants (05/01/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $0) with ownership activity and broader fundamentals.